Neuphoria Therapeutics Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q42026 FY2026 | $-0.56 | — | — | Miss |
| Q32026 FY2026 | $-0.56 | $-0.09 | +83.9% | Beat |
| Q22026 FY2026 | $-0.56 | — | — | Miss |
Back to NEUP overview · NEUP holders · NEUP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.